Cargando…

Multimodal imaging evaluation of a primary cardiac lymphoma in an immunocompetent patient

Primary cardiac lymphoma (PCL) is a rare extranodal lymphoma that involves only the heart and/or pericardium. It is fatal in the absence of a prompt diagnosis and adequate therapy. Here, we report an immunocompetent 55‐year‐old Chinese man with palpitations and occasional chest distress for 1 month....

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shuyuan, Li, Meng, Zhang, Li, Xie, Mingxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585775/
https://www.ncbi.nlm.nih.gov/pubmed/30315591
http://dx.doi.org/10.1111/echo.14150
_version_ 1783428771310731264
author Wang, Shuyuan
Li, Meng
Zhang, Li
Xie, Mingxing
author_facet Wang, Shuyuan
Li, Meng
Zhang, Li
Xie, Mingxing
author_sort Wang, Shuyuan
collection PubMed
description Primary cardiac lymphoma (PCL) is a rare extranodal lymphoma that involves only the heart and/or pericardium. It is fatal in the absence of a prompt diagnosis and adequate therapy. Here, we report an immunocompetent 55‐year‐old Chinese man with palpitations and occasional chest distress for 1 month. Multimodal imaging work‐up showed a tumor infiltrated into the myocardium, which greatly contribute to a timely pathology diagnosis of PCL.
format Online
Article
Text
id pubmed-6585775
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-65857752019-06-27 Multimodal imaging evaluation of a primary cardiac lymphoma in an immunocompetent patient Wang, Shuyuan Li, Meng Zhang, Li Xie, Mingxing Echocardiography IMAGES Section Editor ‐ Brian D. Hoit, MD Primary cardiac lymphoma (PCL) is a rare extranodal lymphoma that involves only the heart and/or pericardium. It is fatal in the absence of a prompt diagnosis and adequate therapy. Here, we report an immunocompetent 55‐year‐old Chinese man with palpitations and occasional chest distress for 1 month. Multimodal imaging work‐up showed a tumor infiltrated into the myocardium, which greatly contribute to a timely pathology diagnosis of PCL. John Wiley and Sons Inc. 2018-10-12 2018-12 /pmc/articles/PMC6585775/ /pubmed/30315591 http://dx.doi.org/10.1111/echo.14150 Text en © 2018 The Authors. Echocardiography Published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle IMAGES Section Editor ‐ Brian D. Hoit, MD
Wang, Shuyuan
Li, Meng
Zhang, Li
Xie, Mingxing
Multimodal imaging evaluation of a primary cardiac lymphoma in an immunocompetent patient
title Multimodal imaging evaluation of a primary cardiac lymphoma in an immunocompetent patient
title_full Multimodal imaging evaluation of a primary cardiac lymphoma in an immunocompetent patient
title_fullStr Multimodal imaging evaluation of a primary cardiac lymphoma in an immunocompetent patient
title_full_unstemmed Multimodal imaging evaluation of a primary cardiac lymphoma in an immunocompetent patient
title_short Multimodal imaging evaluation of a primary cardiac lymphoma in an immunocompetent patient
title_sort multimodal imaging evaluation of a primary cardiac lymphoma in an immunocompetent patient
topic IMAGES Section Editor ‐ Brian D. Hoit, MD
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585775/
https://www.ncbi.nlm.nih.gov/pubmed/30315591
http://dx.doi.org/10.1111/echo.14150
work_keys_str_mv AT wangshuyuan multimodalimagingevaluationofaprimarycardiaclymphomainanimmunocompetentpatient
AT limeng multimodalimagingevaluationofaprimarycardiaclymphomainanimmunocompetentpatient
AT zhangli multimodalimagingevaluationofaprimarycardiaclymphomainanimmunocompetentpatient
AT xiemingxing multimodalimagingevaluationofaprimarycardiaclymphomainanimmunocompetentpatient